Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex
Open Access
- 13 December 2019
- Vol. 24 (24), 4567
- https://doi.org/10.3390/molecules24244567
Abstract
Alkaloids having acetylcholinesterase (AChE) inhibitory activity are commonly found in traditional Chinese medicine (TCM); for example, berberine from Coptis chinensis, galantamine from Lycoris radiata, and huperzine A from Huperzia serrata. In practice of TCM, Stephaniae Tetrandrae Radix (STR) is often combined with Coptidis Rhizoma (CR) or Phellodendri Chinensis Cortex (PCC) as paired herbs during clinical application. Fangchinoline from STR and coptisine and/or berberine from CR and/or PCC are active alkaloids in inhibiting AChE. The traditional usage of paired herbs suggests the synergistic effect of fangchinoline–coptisine or fangchinoline–berberine pairing in AChE inhibition. HPLC was applied to identify the main components in herbal extracts of STR, CR, and PCC, and the AChE inhibition of their main components was determined by Ellman assay. The synergism of herb combination and active component combination was calculated by median-effect principle. Molecular docking was applied to investigate the underlying binding mechanisms of the active components with the AChE protein. It was found that fangchinoline showed AChE inhibitory potency; furthermore, fangchinoline–coptisine/berberine pairs (at ratios of 1:5, 1:2, 1:1, and 2:1) synergistically inhibited AChE; the combination index (CI) at different ratios was less than one when Fa = 0.5, suggesting synergistic inhibition of AChE. Furthermore, the molecular docking simulation supported this enzymatic inhibition. Therefore, fangchinoline–coptisine/berberine pairs, or their parental herbal mixtures, may potentially be developed as a possible therapeutic strategy for Alzheimer’s patients.Keywords
Funding Information
- China Postdoctoral Science Foundation (2019M653087)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20170413173747440, JCYJ20160229205812004, ZDSYS201707281432317)
This publication has 53 references indexed in Scilit:
- Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s diseaseTranslational Neurodegeneration, 2013
- Acetylcholinesterase: old questions and new developmentsFrontiers in Molecular Neuroscience, 2013
- Liuwei Dihuang (LWDH), a Traditional Chinese Medicinal Formula, Protects against β-Amyloid Toxicity in Transgenic Caenorhabditis elegansPLOS ONE, 2012
- Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s DiseaseMolecules, 2011
- A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene ActivationEvidence-Based Complementary and Alternative Medicine, 2011
- Fangchinoline inhibits glutamate release from rat cerebral cortex nerve terminals (synaptosomes)Neurochemistry International, 2009
- Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulaeChinese Medicine, 2007
- The significance of the cholinergic system in the brain during aging and in Alzheimer’s diseaseJournal of Neural Transmission, 2006
- Investigation of the binding mode of (−)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking methodJournal of Molecular Modeling, 2006
- Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrilsJournal of Molecular Biology, 1997